Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: A Go-DARTS study

Pharmacogenetics and Genomics

Volumn 18, Issue 4, 2008, Pages 279-287

  Donnelly, Louise A ^b   Palmer, Colin N A ^c,e   Whitley, Adrian L ^c   Lang, Chim Choy ^d   Doney, Alex S F ^d   Morris, Andrew D ^d   Donnan, Peter T ^a  

^a Tayside Centre for General Practice

^b Division of Community Health Sciences   (Canada)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d NINEWELLS HOSPITAL   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Apolipoproteins; Diabetes mellitus; Lipoproteins; Statins

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN E; ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

ADULT; ALLELE; APOE GENE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; GENE; GENETIC ASSOCIATION; GENETICS OF DIABETES AUDIT AND RESEARCH IN TAYSIDE SCOTLAND STUDY; GENOTYPE; HOMOZYGOTE; HUMAN; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT RESPONSE; UNITED KINGDOM;

ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS E; CHOLESTEROL, LDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, MONOUNSATURATED; FEMALE; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PRAVASTATIN; PYRIDINES; RETROSPECTIVE STUDIES; SCOTLAND; SIMVASTATIN; TREATMENT OUTCOME;

EID: 40549130372     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3282f60aad     Document Type: Article

References (37)